Pharmacokinetics of fenfluramine and norfenfluramine in volunteers given D- and DL-fenfluramine for 15 days. 1985

S Caccia, and I Conforti, and J Duchier, and S Garattini

The kinetics of accumulation and elimination of d- and l-fenfluramine (F) and norfenfluramine (NF) have been studied in 8 young healthy volunteers given daily doses of 60 mg of sugar-coated tablets of 20 mg dl-F hydrochloride (dl-F) t.i.d. and capsules of 15 mg d-F hydrochloride (d-F) b.i.d. for 15 days. Repeated doses of d-F plus l-F gave the same values for the parameters measured as did d-F administered alone. Steady-state concentrations of all compounds were achieved within 4-8 days. The predicted mean steady-state concentrations of d-F and elimination half-lives calculated from the results of a previous single dose study were similar to those measured at steady state in this study, confirming the lack of effect of the drug on hepatic microsomal enzymes and on kinetics after repeated dosing. d-NF concentrations were approximately half those of the parent drug and the half-life was almost twice as long. Steady state concentrations both of L-f and l-NF were consistently about 40-50% higher than of the d-isomers and there was a comparable in the half-life.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D009642 Norfenfluramine A FENFLURAMINE analog that inhibits serotonin uptake and may provoke release of serotonin. It is used as an appetite depressant and an experimental tool in animal studies. Dexnorfenfluramine,Nordexfenfluramine
D005260 Female Females
D005277 Fenfluramine A centrally active drug that apparently both blocks serotonin uptake and provokes transport-mediated serotonin release. Fintepla,Fenfluramine Hydrochloride,Fenfluramine Hydrochloride, (+-)-Isomer,Fenfluramine Hydrochloride, R-Isomer,Fenfluramine, (+-)-Isomer,Fenfluramine, R-Isomer,Isomeride,Pondimin,Fenfluramine Hydrochloride, R Isomer,Fenfluramine, R Isomer,Hydrochloride, Fenfluramine
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013237 Stereoisomerism The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Molecular Stereochemistry,Stereoisomers,Stereochemistry, Molecular,Stereoisomer

Related Publications

S Caccia, and I Conforti, and J Duchier, and S Garattini
December 1988, Journal of chromatography,
S Caccia, and I Conforti, and J Duchier, and S Garattini
March 1983, Journal of neurochemistry,
S Caccia, and I Conforti, and J Duchier, and S Garattini
March 2024, Journal of clinical pharmacology,
S Caccia, and I Conforti, and J Duchier, and S Garattini
November 2001, Journal of chromatography. B, Biomedical sciences and applications,
S Caccia, and I Conforti, and J Duchier, and S Garattini
January 1995, Life sciences,
S Caccia, and I Conforti, and J Duchier, and S Garattini
October 1994, European journal of pharmacology,
S Caccia, and I Conforti, and J Duchier, and S Garattini
December 1990, Brain research bulletin,
S Caccia, and I Conforti, and J Duchier, and S Garattini
March 1993, European journal of pharmacology,
S Caccia, and I Conforti, and J Duchier, and S Garattini
September 1993, European journal of pharmacology,
S Caccia, and I Conforti, and J Duchier, and S Garattini
March 1990, Pharmacology, biochemistry, and behavior,
Copied contents to your clipboard!